Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma

Jian Jian Kang; Pengxu Qian; Vijay Pandey; Jo K. Perry; Lance D. Miller; E T Liu; Tao Zhu; Danxia Liu; Peter E. Lobie

doi:10.1038/onc.2010.71

Article2010

Trefoil Factor 3 Is Oncogenic and Mediates Anti-Estrogen Resistance in Human Mammary Carcinoma

Nagarajan Kannan, Jian Jian Kang, Xiangjun Kong, Jian‐Zhong Tang, Jo K. Perry, Kumarasamypet M. Mohankumar, Lance D. Miller, Edison T. Liu, Hichem C. Mertani, Tao Zhu, Prudence M. Grandison, Dongxu Liu, Peter E. Lobie

Article2009

Artemin is oncogenic for human mammary carcinoma cells

Jian Jian Kang, Jo K. Perry, Vijay Pandey, Graeme C. Fielder, Bin Mei, Pengxu Qian, Zimei Wu, Tao Zhu, Danxia Liu, Peter E. Lobie

Article2011

ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma

Arindam Banerjee, Zhengsheng Wu, Pengxu Qian, Jian Jian Kang, Vijay Pandey, Dongxu Liu, Tao Zhu, Peter E. Lobie

Article2012

ARTEMIN Promotes De Novo Angiogenesis in ER Negative Mammary Carcinoma through Activation of TWIST1-VEGF-A Signalling

Arindam Banerjee, Zhengsheng Wu, Pengxu Qian, Jian Jian Kang, Dongxu Liu, Tao Zhu, Peter E. Lobie

Article2010

Artemin-Stimulated Progression of Human Non–Small Cell Lung Carcinoma Is Mediated by BCL2

Jian‐Zhong Tang, Xiangjun Kong, Jian Jian Kang, Graeme C. Fielder, Michael Steiner, Jo K. Perry, Zhengsheng Wu, Zhinan Yin, Tao Zhu, Dongxu Liu, Peter E. Lobie

Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma

Discussion(0)

Related publications

Trefoil Factor 3 Is Oncogenic and Mediates Anti-Estrogen Resistance in Human Mammary Carcinoma

Artemin is oncogenic for human mammary carcinoma cells

ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma

ARTEMIN Promotes De Novo Angiogenesis in ER Negative Mammary Carcinoma through Activation of TWIST1-VEGF-A Signalling

Artemin-Stimulated Progression of Human Non–Small Cell Lung Carcinoma Is Mediated by BCL2